November 18, 2022
RaQualia Pharma said on November 17 that it will receive a lump sum payment of US$4 million from Asahi Kasei Pharma, as their jointly discovered P2X7 receptor antagonist has entered a global PII clinical trial by Eli Lilly for the...read more